Antimetabolites: all 7,305 studies that test it
Page 34 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Venetoclax in Patients With MDS or AML in Relapse After AHSCTActive, not recruitingNCT05226455Phase 1/2
- Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With VenetoclaxActive, not recruitingNCT05222984Phase 1
- DPC in Primary Molars.CompletedNCT05222243Phase 4
- A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR ExpressionStatus unknownNCT05215925Phase 2
- Adavosertib and Gemcitabine in Advanced PancreaticWithdrawnNCT05212025Phase 2
- A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid MalignanciesTerminatedNCT05209295Phase 1
- THIO Sequenced With Cemiplimab in Advanced NSCLCActive, not recruitingNCT05208944Phase 2
- Medical Treatment in Ectopic Tubal PregnancyCompletedNCT05208034Not applicable
- Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT05204173Phase 2
- Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, FluoropyrimidineActive, not recruitingNCT05201352Phase 1/2
- A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic MalignanciesWithdrawnNCT05201183Phase 1/2
- Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)Active, not recruitingNCT05200481Phase 2
- Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly PatientsCompletedNCT05188326Phase 3
- Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the LiverCompletedNCT05182112Phase 1
- Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AMLActive, not recruitingNCT05177731Phase 3
- Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDSStatus unknownNCT05175508Phase 2/3
- Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy IndividualsCompletedNCT05167084Early Phase 1
- CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or RelapsedActive, not recruitingNCT05162976Phase 1
- A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.CompletedNCT05155709Phase 1
- RALOX as Second Line Treatment for Advanced Malignant Biliary System TumorStatus unknownNCT05148143Phase 2
- Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaActive, not recruitingNCT05144243Phase 4
- Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic LeukemiaActive, not recruitingNCT05141682Phase 1/2
- 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05139004Phase 1
- A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese ParticipantsCompletedNCT05136677Phase 2
- A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast CancerTerminatedNCT05134194Phase 3
- A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-CancerStatus unknownNCT05132413Phase 3
- Clinical Experience of Thalidomide in Thalassemic PatientsCompletedNCT05132270Phase 2/3
- A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal CancerCompletedNCT05130060Phase 1
- Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of AtherosclerosisCompletedNCT05118542Phase 3
- An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Active, not recruitingNCT05112965Phase 3
- Adaptive Radiation for Locally Advanced Rectal AdenocarcinomaActive, not recruitingNCT05108428Early Phase 1
- Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell LymphomasTerminatedNCT05105412Phase 1/2
- Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast CancerStatus unknownNCT05089643Phase 2
- Repeated iTBS Cycloserine Motor PlasticityCompletedNCT05081986Phase 2
- Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell AnemiaCompletedNCT05081349Phase 4
- Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic KeratosisCompletedNCT05078827Phase 3
- Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric CancerStatus unknownNCT05070598Phase 2
- Duvelisib in Combination With BMS-986345 in Lymphoid MalignancyCompletedNCT05065866Phase 1
- Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast CancerCompletedNCT05064085Phase 1
- Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer PatientsSuspendedNCT05062889Phase 2
- Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell LymphomaCompletedNCT05058755Not applicable
- Intralesional Treatment of Plantar WartStatus unknownNCT05057663Not applicable
- Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AMLStatus unknownNCT05053425Not applicable
- Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNCT05052528Phase 1
- PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerCompletedNCT05052437Phase 1
- Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)TerminatedNCT05049863Phase 1
- Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.Status unknownNCT05049473Phase 2
- Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AMLCompletedNCT05048615Phase 2
- Pharmacokinetics, Tolerability and Safety of NEX-18aCompletedNCT05048498Phase 1
- Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic SyndromesActive, not recruitingNCT05038592Phase 1/2
- A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSLCompletedNCT05036577Phase 1
- Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial CarcinomaStatus unknownNCT05030077Phase 2
- HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCCStatus unknownNCT05029973Phase 2
- Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived OrganoidsActive, not recruitingNCT05024734Phase 2
- Biliary Drainage Plus HAIC in Locally Advanced pCCACompletedNCT05024513Phase 2
- TriPRIL CAR T Cells in Multiple MyelomaActive, not recruitingNCT05020444Phase 1
- FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal CancerStatus unknownNCT05018182Phase 2
- Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal CancerStatus unknownNCT05016869Phase 1/2
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American PatientsActive, not recruitingNCT05014646Phase 2
- Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental VitiligoStatus unknownNCT05008887Phase 4
- Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLHStatus unknownNCT05008666Phase 2
- Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple MyelomaStatus unknownNCT05008536Early Phase 1
- Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus DiseaseCompletedNCT05007678Phase 3
- Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRCStatus unknownNCT05004831Phase 2
- Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerActive, not recruitingNCT05003037Phase 2
- Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node MetastasisStatus unknownNCT05002686Phase 2/3
- A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.Status unknownNCT04999878Phase 4
- Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid LeukemiaTerminatedNCT04994808Phase 2
- Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative NeoplasmCompletedNCT04992949Phase 2
- A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic SyndromesWithdrawnNCT04985656Phase 2
- Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled TrialCompletedNCT04983160Phase 2
- Induction Therapy for Patients With FLT3 Mutated Acute Myeloid LeukemiaWithdrawnNCT04982354Phase 1/2
- Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC TreatmentStatus unknownNCT04970043Not applicable
- Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid LeukemiaTerminatedNCT04964505Phase 1
- Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and LeukemiaWithdrawnNCT04961801Phase 1/2
- MTX and Steroid as First-line Therapy for aGVHDCompletedNCT04960644Phase 3
- Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary SyndromeActive, not recruitingNCT04960618Phase 2
- MTX and Steroid for III-IV aGVHD TreatmentStatus unknownNCT04958538Phase 2
- Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa EpendymomaCompletedNCT04958486Early Phase 1
- Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT04956042Phase 1/2
- Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCCActive, not recruitingNCT04947241Phase 1
- Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)CompletedNCT04942730Phase 2
- Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer PatientsCompletedNCT04942626Phase 1
- Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic CancerActive, not recruitingNCT04940286Phase 2
- Perioperative Chemotherapy in Gastric CancerTerminatedNCT04937738Phase 2
- Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT04934579Phase 2
- Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell TransplantTerminatedNCT04932564Phase 2
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerActive, not recruitingNCT04929028Phase 2
- Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerActive, not recruitingNCT04927780Phase 3
- Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell CancerStatus unknownNCT04926753Phase 1
- TAS-102 in Patients With Advanced, Refractory Pancreatic AdenocarcinomaCompletedNCT04923529Phase 2
- Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal CancerActive, not recruitingNCT04922853Phase 3
- GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell LymphomaStatus unknownNCT04917250Phase 2
- Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid LeukemiaCompletedNCT04915612Phase 1
- HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
- Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRLStatus unknownNCT04899453Phase 2
- Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell LymphomaStatus unknownNCT04899414Phase 2
- HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.TerminatedNCT04898504Phase 2
- Monitoring the Efficacy of Duvalizumab Combined With Neoadjuvant Chemotherapy for Ib-IIIb NSCLC by Sequencing of Immune Receptor Repertoire: a Prospective, One Arm Clinical StudyStatus unknownNCT04897386Phase 2
- Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma PatientsTerminatedNCT04894123Phase 2